{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:06:13Z","timestamp":1778155573877,"version":"3.51.4"},"reference-count":101,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1742-1241.2008.01877.x","type":"journal-article","created":{"date-parts":[[2008,9,15]],"date-time":"2008-09-15T09:32:21Z","timestamp":1221471141000},"page":"160-169","source":"Crossref","is-referenced-by-count":27,"title":["Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome"],"prefix":"10.1155","volume":"63","author":[{"given":"G. M.","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. S.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"de Paula Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. F. S.","family":"de S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Ferriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","article-title":"Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women","volume":"84","author":"Carmina","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/09513590009167709","article-title":"Polycystic ovary syndrome: an endocrine and metabolic disease","volume":"14","author":"Scarpitta","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB4","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.crd.0000380842.14048.7e","article-title":"Diagnosis and management of the metabolic syndrome. An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary","volume":"13","author":"Grundy","year":"2005","journal-title":"Cardiol Rev"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.28.2.385","article-title":"The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study","volume":"28","author":"McNeill","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB8","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1093\/humrep\/dei221","article-title":"Metabolic syndrome in young Czech women with polycystic ovary syndrome","volume":"20","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.fertnstert.2007.03.081","article-title":"Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome","volume":"89","author":"Soares","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB10","first-page":"281","article-title":"Polycystic ovary syndrome, metabolic syndrome, cardiovascular risk and the role of insulin sensitizing agents","volume":"50","author":"Silva Rdo","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmi005","article-title":"Combined oral contraceptives in the treatment of polycystic ovary syndrome","volume":"11","author":"Vrbikova","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/humrep\/del407","article-title":"Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis","volume":"22","author":"Nader","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bpobgyn.2004.05.004","article-title":"The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology","volume":"18","author":"Balen","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9378(73)90890-9","article-title":"One-hour glucose tolerance in relation to the use of contraceptive drugs","volume":"116","author":"Phillips","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0022-4731(75)90333-7","article-title":"Effects of oral contraceptive agents on carbohydrate metabolism","volume":"6","author":"Kalkhoff","year":"1975","journal-title":"J Steroid Biochem"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0010-7824(02)00537-1","article-title":"A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism","volume":"67","author":"Gaspard","year":"2003","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/BF00401427","article-title":"Oral contraceptive use and the risk of type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women","volume":"35","author":"Rimm","year":"1992","journal-title":"Diabetologia"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.20.3.330","article-title":"A prospective study of oral contraceptives and NIDDM among U.S. women","volume":"20","author":"Chasan-Taber","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB20","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006133.pub2","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","author":"Lopez","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0015-0282(00)00718-4","article-title":"Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity","volume":"74","author":"Escobar-Morreale","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB23","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","article-title":"Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel","volume":"88","author":"Cagnacci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB24","first-page":"3074","article-title":"The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women","volume":"82","author":"Nader","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","article-title":"Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome","volume":"85","author":"Mastorakos","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB28","author":"World Health Organization","year":"2004"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","article-title":"Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives","volume":"77","author":"Mastorakos","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2006-1705","article-title":"Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome","volume":"92","author":"Berneis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.maturitas.2003.10.013","article-title":"Biology: risk factor modification by OCs and HRT lipids and lipoproteins","volume":"47","author":"Godsland","year":"2004","journal-title":"Maturitas"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0010-7824(01)00269-4","article-title":"The effects of two progestogen-only pills containing either desogestrel (75\u2003\u03bcg\/day) or levonorgestrel (30\u2003\u03bcg\/day) on lipid metabolism","volume":"64","author":"Barkfeldt","year":"2001","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB33","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.11.137","article-title":"Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome","volume":"88","author":"De Leo","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","article-title":"Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism","volume":"85","author":"Batukan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2265.2007.03105.x","article-title":"A systematic review of commonly used medical treatments for hirsutism in women","volume":"68","author":"Koulouri","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB41","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.fertnstert.2006.07.1507","article-title":"Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study","volume":"87","author":"Sanchez","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB42","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB43","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB44","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1210\/jc.2003-032110","article-title":"The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB45","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB47","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB48","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB49","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus","volume":"98","author":"Dunaif","year":"1995","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB50","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3324\/haematol.10828","article-title":"Venous thromboembolism - a manifestation of the metabolic syndrome","volume":"92","author":"Ay","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","article-title":"The plasminogen activator system in women with polycystic ovary syndrome","volume":"69","author":"Atiomo","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.thromres.2004.11.026","article-title":"Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome","volume":"116","author":"Carmassi","year":"2005","journal-title":"Thromb Res"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)56575-3","article-title":"Hemostatic and metabolic variables in women with polycystic ovary syndrome","volume":"61","author":"Dahlgren","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB55","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0015-0282(00)01614-9","article-title":"Are women with polycystic ovary syndrome resistant to activated protein C?","volume":"74","author":"Atiomo","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2265.2000.00946.x","article-title":"Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)","volume":"52","author":"Atiomo","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB57","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB58","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1538-7836.2003.00264.x","article-title":"Estrogens, progestogens and thrombosis","volume":"1","author":"Rosendaal","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hq0202.102318","article-title":"Female hormones and thrombosis","volume":"22","author":"Rosendaal","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB60","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0889-8588(05)70170-2","article-title":"Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease","volume":"14","author":"Mammen","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2005.1.1","article-title":"Venous thrombosis: the role of genes, environment, and behavior","author":"Rosendaal","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB62","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","author":"WHO","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2141.1997.192707.x","article-title":"Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives","volume":"97","author":"Rosing","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB65","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB66","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/humupd\/5.6.672","article-title":"Biological coagulation findings in third-generation oral contraceptives","volume":"5","author":"Conard","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB69","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB70","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humrep\/deg120","article-title":"The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study","volume":"18","author":"Seaman","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB71","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1538-7836.2004.00894.x","article-title":"Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives","volume":"2","author":"Alhenc-Gelas","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB72","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1538-7836.2004.00983.x","article-title":"Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate","volume":"2","author":"van Vliet","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB73","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"van Vliet","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB74","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB75","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB76","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10110","article-title":"Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study","volume":"10","author":"Wu","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB78","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1160\/TH05-03-0682","article-title":"Transitory reduction of platelet aggregation with the use of etonogestrel implant in healthy women","volume":"94","author":"Vieira","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB79","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/humrep\/dem153","article-title":"Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade","volume":"22","author":"Vieira","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB81","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB82","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dei070","article-title":"Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB84","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.HYP.0000145474.23750.2b","article-title":"Gender-specific influence of NO synthase gene on blood pressure since childhood: the Bogalusa Heart Study","volume":"44","author":"Chen","year":"2004","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB85","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone, a progestogen with antimineralocorticoid properties: a short review","volume":"217","author":"Oelkers","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.maturitas.2006.07.009","article-title":"Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism","volume":"55","author":"Palacios","year":"2006","journal-title":"Maturitas"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2008.01877.x-BIB88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697130500330341","article-title":"Drospirenone in combination with estrogens: for contraception and hormone replacement therapy","volume":"8","author":"Oelkers","year":"2005","journal-title":"Climacteric"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB89","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2005.08.005","article-title":"Combined oral contraceptive use among women with hypertension: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB90","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1471-0528.1984.tb04747.x","article-title":"A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen","volume":"91","author":"Wilson","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB91","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0010-7824(02)00429-8","article-title":"Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women","volume":"67","author":"Lubianca","year":"2003","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB93","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.jhh.1001841","article-title":"Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension","volume":"19","author":"Lubianca","year":"2005","journal-title":"J Hum Hypertens"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB94","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003987.pub2","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0002-9378(11)91626-3","article-title":"Suppression of 24-hour cholecystokinin secretion by oral contraceptives","volume":"167","author":"Karlsson","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB96","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB97","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.contraception.2007.06.008","article-title":"Contraceptive discontinuation attributed to method dissatisfaction in the United States","volume":"76","author":"Moreau","year":"2007","journal-title":"Contraception"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB98","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method","volume":"160","author":"Bonny","year":"2006","journal-title":"Arch Pediatr Adolesc Med."},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB99","first-page":"427","article-title":"Weight gain on the combined pill-is it real?","volume-title":"Human Reproduction Update","volume":"6","author":"Gupta","year":"2000"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB100","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2337\/dc07-0180","article-title":"A longitudinal study of lipids and blood pressure in relation to method of contraception in Latino women with prior gestational diabetes mellitus","volume":"30","author":"Xiang","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01877.x-BIB101","first-page":"119","article-title":"Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary","volume":"40","author":"Vrbikova","year":"2006","journal-title":"Endocr Regul"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2008.01877.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2008.01877.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:07:57Z","timestamp":1643350077000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2008.01877.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01877.x","relation":{},"ISSN":["1368-5031","1742-1241"],"issn-type":[{"value":"1368-5031","type":"print"},{"value":"1742-1241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}